Get the Stockscreener App
1.46
1.35%
-0.02
After Hours:
1.46
Curis Inc stock is traded at $1.46, with a volume of 48,965.
It is down -1.35% in the last 24 hours and down -11.52% over the past month.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
See More
Previous Close:
$1.48
Open:
$1.46
24h Volume:
48,965
Relative Volume:
0.70
Market Cap:
$18.25M
Revenue:
$11.41M
Net Income/Loss:
$-38.92M
P/E Ratio:
-0.299
EPS:
-4.8828
Net Cash Flow:
$-30.46M
1W Performance:
-2.67%
1M Performance:
-11.52%
6M Performance:
-39.42%
1Y Performance:
-66.28%
1-Day Range:
$1.431
$1.48
1-Week Range:
$1.431
$1.59
52-Week Range:
$1.02
$5.00
Curis Inc Stock (CRIS) Company Profile
Name
Curis Inc
Sector
Industry
Phone
617-503-6500
Address
128 SPRING STREET, LEXINGTON, MA
Compare CRIS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.46 | 18.50M | 11.41M | -38.92M | -30.46M | -4.8828 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Apr-04-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Jul-29-20 | Initiated | Laidlaw | Buy |
| Jul-17-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Mar-02-16 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Nov-09-15 | Reiterated | ROTH Capital | Buy |
| Aug-11-15 | Initiated | FBR Capital | Outperform |
| Jan-22-15 | Reiterated | Oppenheimer | Outperform |
| Jan-21-15 | Reiterated | ROTH Capital | Buy |
| May-09-14 | Reiterated | Oppenheimer | Outperform |
| Oct-02-13 | Initiated | Robert W. Baird | Outperform |
| Sep-30-13 | Initiated | Chardan Capital Markets | Buy |
| Nov-14-12 | Initiated | Stifel Nicolaus | Hold |
| Jan-31-12 | Reiterated | Brean Murray | Buy |
| Jan-31-12 | Reiterated | Summer Street Research | Buy |
| Dec-09-11 | Initiated | Oppenheimer | Outperform |
| Oct-06-11 | Initiated | Summer Street Research | Buy |
| Sep-22-11 | Initiated | MLV Capital | Buy |
| Mar-21-11 | Reiterated | Brean Murray | Buy |
| Feb-26-10 | Reiterated | Roth Capital | Buy |
| Jan-07-10 | Initiated | Roth Capital | Buy |
View All
Curis Inc Stock (CRIS) Latest News
How Curis Inc. stock compares to industry benchmarksInsider Buying & AI Enhanced Trading Signals - newser.com
Applying Wyckoff theory to Curis Inc. stock2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
How hedge fund analytics apply to Curis Inc. stock2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
What the charts say about Curis Inc. todayJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Will Curis Inc. (CUS0) stock gain from lower interest ratesQuarterly Risk Review & Low Risk High Reward Ideas - newser.com
Can a trend reversal in Curis Inc. lead to recoveryEarnings Risk Report & Expert Approved Trade Ideas - newser.com
Can Curis Inc. stock sustain revenue growthInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Can Curis Inc. (CUS0) stock sustain breakout momentumJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
How Curis Inc. stock performs in high volatility markets2025 Technical Patterns & Free Community Consensus Stock Picks - newser.com
Is Curis Inc. (CUS0) stock a top hedge fund pick2025 Year in Review & Real-Time Volume Analysis Alerts - newser.com
Detecting support and resistance levels for Curis Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
How Curis Inc. stock responds to policy changesMarket Rally & High Conviction Buy Zone Alerts - newser.com
Is Curis Inc. stock attractive for income investorsJuly 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 - Barchart.com
2025-10-30 | Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 | NDAQ:CRIS | Press Release - Stockhouse
What analysts say about Curis Inc stockREITs Market Trends & Free Fastest Return On Investment - earlytimes.in
Curis Stock Fell 7.7% in a Month, What Now? - Trefis
How buybacks impact Curis Inc. stock valueMarket Growth Report & Free Real-Time Volume Trigger Notifications - Fundação Cultural do Pará
Is Curis Inc. (CUS0) stock included in top ETFs2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Can Curis Inc. stock resist sector downturnsJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - fcp.pa.gov.br
Should You Invest in Ducon Infratechnologies Limited Before Its Next Earnings ReportSwing Trading Ideas & Get Alerts on Stocks Set to Skyrocket - earlytimes.in
Curis Inc Stock (CRIS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):